Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2013 by West China Second University Hospital.
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborators:
Sichuan Academy of Medical Sciences
people's hospital of Guang'an
The first people's hospital of Neijiang
Suining Central Hospital
Sichuan Provincial Maternal and Child Health Care Hospital
Chengdu Women's and Children's Central Hospital
Luzhou Medical College
pengzhou shi fuyou baojianyuan
Nanchong Central Hospital
Information provided by (Responsible Party):
Xinghui Liu, West China Second University Hospital
ClinicalTrials.gov Identifier:
NCT01804751
First received: March 1, 2013
Last updated: August 24, 2015
Last verified: June 2013
  Purpose
The purpose of this study is to build a model for the prediction of adverse perinatal outcome for preeclampsia in china

Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by West China Second University Hospital:

Primary Outcome Measures:
  • maternal mortality [ Time Frame: within 48h of eligibility ]

Secondary Outcome Measures:
  • serious central nervous system morbidity [ Time Frame: within 48h of eligibility ]
  • serious cardiorespiratory morbidity [ Time Frame: within 48h of eligibility ]
  • serious hepatic morbidity. [ Time Frame: within 48h of eligibility ]
  • serious renal morbidity [ Time Frame: within 48h of eligibility ]
  • serious haematological morbidity [ Time Frame: within 48h of eligibility ]

Study Start Date: January 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Chinese women who fulfilled a research definition of preeclampsia, and who were admitted to participating obstetric centres
Criteria

Inclusion Criteria:

  • admitted with preeclampsia or had developed preeclampsia after admission

Exclusion Criteria:

  • admitted in spontaneous labour or had achieved any component of the maternal outcome before either fulfilling eligibility criteria or collection of predictor data
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Xinghui Liu, professor, West China Second University Hospital
ClinicalTrials.gov Identifier: NCT01804751     History of Changes
Other Study ID Numbers: hx2ck2 
Study First Received: March 1, 2013
Last Updated: August 24, 2015
Health Authority: China:science & technology department of sichuan province

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on December 07, 2016